FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: This discovery rapidly led to the identification of FOXP3 mutations in human IPEX patients, firmly establishing FOXP3 as a central regulator of immune tolerance (6–8).